Expression and regulation of phospholipase D isoforms in sphingosine and phorbol ester-stimulated glioma C6 cells

• Published in: Biochemical and biophysical research communications 2004-05, Vol.317 (3), p.689-696
• Main Authors: Bobeszko, Marta, Krzemiński, Patryk, Pomorski, Paweł, Dygas, Anna, Barańska, Jolanta
• Format: Article
• Language: English
• Subjects: Base Sequence; Cell Line, Tumor; DNA Primers; Glioma C6 cells; Humans; Isoenzymes - genetics; Isoenzymes - metabolism; Phospholipase D - genetics; Phospholipase D - metabolism; Phospholipase D isoforms expression; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger - genetics; RNA, Messenger - metabolism; Sphingosine; Sphingosine - pharmacology; Tetradecanoylphorbol Acetate - pharmacology; TPA
• ISSN: 0006-291X; 1090-2104
• DOI: 10.1016/j.bbrc.2004.03.105

Previously we have reported that in glioma C6 cells, sphingosine stimulatory effect on phospholipase D (PLD) activity is independent of protein kinase C [Cell. Signal. 12 (2000) 399]. In this paper we have shown that this effect was also GTPγS independent and was completely inhibited by the plasma membrane methyl-β-cyclodextrin cholesterol depletion what destroys caveolae structure. On the contrary, phorbol ester (12- O-tetradecanoylphorbol-13-acetate, TPA)-mediated PLD activity was enhanced by GTPγS and was only partially decreased by methyl-β-cyclodextrin. We have also shown that TPA significantly increased expression of PLD1a and PLD1b mRNAs and had lower effect on PLD2 mRNA. Sphingosine only slightly increased expression of PLD mRNA isoforms and did not cause synergistic effect when applied together with TPA. These results indicate that TPA, but not sphingosine, stimulates transcriptional activity of PLD isoforms. We also suggest that TPA stimulates primarily PLD1, while sphingosine affects PLD2 activity. This last process might occur at plasma membrane lipid microdomains.